Psoriasis is a consistently recurring, inflammatory, autoimmune disorder of the skin, affecting
about 2–5% of the world population. Abundant therapeutic agents are accessible for the …

Psoriasis is a lingering inflammatory skin disease that attacks the immune system. The
abnormal interactions between T cells, immune cells, and inflammatory cytokines causing …

To enhance anthralin efficacy against psoriasis and reduce its notorious side effects, it was
loaded into various liposomal and ethosomal preparations. The nanocarriers were …

Psoriasis is a chronic inflammatory non-contagious disease normally characterized by a
multisystemic inflammation with reddish plaques and whitish scales with greater incidence …

Background: For the past few decades, there has been considerable research interest in
drug delivery strategies using nanoparticulate systems as carriers for a wide range of active …

Psoriasis is a serious condition of the skin which is marked by inflammation and hyper-
proliferation of keratinocytes. Because of the complex nature of the disease, it has a …

Although phenytoin is an antiepileptic drug used in the oral treatment of epilepsy, its off-label
use as a cutaneous healing agent has been studied in recent years due to the frequent …

Objective: The aim of this study was to formulate nanostructured lipid carriers (NLCs) of
dithranol-loaded in gel for ease of application and to evaluate its anti-psoriatic efficacy vis-a …

Trichomonas vaginalis infection is the STI most common worldwide. Indole-3-carbinol (I3C)
is a phytochemical presenting promising biological activities. In this study, design …

Dithranol is one of the important topical agents for the treatment of psoriasis, a chronic
inflammatory skin disease with aberrant differentiation of keratinocytes. However, its …